Medovex Corp. Common Stock
MDVX
MDVX was delisted on the 15th of November, 2017.
8 hedge funds and large institutions have $100K invested in Medovex Corp. Common Stock in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 0 closing their positions.
33% more funds holding
Funds holding: 6 → 8 (+2)
22% more capital invested
Capital invested by funds: $82K → $100K (+$18K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIC
Meridian Investment Counsel
Lafayette,
California
|
+$62.4K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$18.8K |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$577 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$54.5K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$2.94K |
| 3 |
Morgan Stanley
New York
|
-$2 |
MDVX Hedge Fund Activity: Q1 2016 in Review
8 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Medovex Corp. Common Stock (MDVX) for Q1 2016, worth a combined $100K — up 22% from $82K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new MDVX positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 3 trimmed.
The largest buyer was Meridian Investment Counsel, opening a new position worth an estimated $62.4K. The largest seller was UBS Group, cutting an estimated $54.5K.
- 8 institutional investors held Medovex Corp. Common Stock (MDVX) as of Q1 2016, up from 6 in Q4 2015.
- Funds reported $100K of Medovex Corp. Common Stock stock for Q1 2016, up 22% quarter-over-quarter.
- 2 funds opened new Medovex Corp. Common Stock positions in Q1 2016 and 0 closed out, a net change of +2 holders.
- The largest Medovex Corp. Common Stock buyer in Q1 2016 was Meridian Investment Counsel, an estimated $62.4K added.
- The largest Medovex Corp. Common Stock seller in Q1 2016 was UBS Group, an estimated $54.5K sold.
Based on aggregated 13F filings for Q1 2016.